ND
NDRA
ENDRA Life Sciences Inc.
$5.55
-0.72%
$6.9M
No data for this timeframe.
Vol
Market Cap$6.9M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$90.1K
Inst. Activity3 buys / 0 sells
SEC Reports2
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001681682·Prev Close $5.59
Recent Activity
May 13, 2026
earnings_calendar
NDRA Q1 2026 Earnings Scheduled — 2026-05-13
Apr 21, 2026
SEC
ENDRA Life Sciences reported Q4 and full-year 2025 financial results with a net loss of $7.0 million for the year, down
8-K — Impact 7/10
Apr 21, 2026
SEC
ENDRA Life Sciences (NDRA) received a delisting notice from Nasdaq due to failing to maintain the minimum stockholders'
8-K — Impact 8/10
Mar 2, 2026
Insider
Tokman Alexander Y sold 26,921 shares
Chief Executive Officer @ $0.00 ($0.00)
Inst.
VANGUARD GROUP INC — NEW
12,937 shares ($58.6K)
Inst.
MORGAN STANLEY — NEW
6,946 shares ($31.5K)
Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$27.00 (Dec 2025)
Current $5.55
Low $27.00
Median $27.00
High $27.00
1 analysts
$27.00
$27.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 8, 2025 | Ascendiant Capital | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-1.14 | $-1.14 — $-1.14 | 33% YoY | 1 |
| Next Q | $-1.14 | $-1.14 — $-1.14 | 46% YoY | 1 |
| Current FY | $-4.65 ▼ -0.6% | $-4.65 — $-4.65 | 39% YoY | 1 |
| Next FY | $-4.00 | $-4.00 — $-4.00 | 14% YoY | 1 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $58.6K | NEW |
| MORGAN STANLEY | $31.5K | NEW |
| BANK OF AMERICA CORP | $45.00 | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 2, 2026 | Tokman Alexander | A | $0.00 |
3 institutional holders with $90.1K total value (19,893 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, BANK. Net buying activity: 3 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 12,937 | $58.6K | 65.0% | NEW |
| 2 | MORGAN STANLEY | 6,946 | $31.5K | 34.9% | NEW |
| 3 | BANK OF AMERICA CORP /DE/ | 10 | $45.00 | 0.0% | ADD +66.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | NEW | — | 12,937 | — | $58.6K | 2025-Q4 |
| MORGAN STANLEY | NEW | — | 6,946 | — | $31.5K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 6 | 10 | +66.7% | $45.00 | 2025-Q4 |
| UBS Group AG | NEAR_EXIT | 4,695 | 106 | -97.7% | $570.00 | 2025-Q3 |
| UBS Group AG | NEW | — | 4,695 | — | $16.5K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 4 | 6 | +50.0% | $21.00 | 2025-Q2 |
1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Tokman Alexander Y | Chief Executive Officer | A | 26,921 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 7.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$27.00 mean target (Dec 2025)
$27.00 Low
$27.00 High
| Metric | Value |
|---|---|
| Current Price | $5.55 |
| Target Low | $27.00 |
| Target Mean | $27.00 |
| Target Median | $27.00 |
| Target High | $27.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-1.14 | $-1.14 | $-1.14 | 33.3% | +0.0% | 1↑ 0↓ | $0.0B | 0.0% | 1 |
| Next Q 2026-09-30 |
$-1.14 | $-1.14 | $-1.14 | 45.7% | +0.0% | 1↑ 0↓ | $0.0B | 0.0% | 1 |
| Current FY 2026-12-31 |
$-4.65 | $-4.65 | $-4.65 | 39.4% | -0.6% | 0↑ 1↓ | $0.0B | 0.0% | 1 |
| Next FY 2027-12-31 |
$-4.00 | $-4.00 | $-4.00 | 14.0% | — | — | $0.0B | 0.0% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-1.140 | |
| 7d ago | $-1.140 | |
| 30d ago | $-1.140 | |
| 60d ago | $-1.140 | |
| 90d ago | $-1.140 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 8, 2025 | Ascendiant Capital | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
NDRA Q1 2026 Earnings Scheduled — 2026-05-13
Mar 30, 2026
earnings_calendar
NDRA Q4 2025 Earnings After Market Close — 2026-03-30